All news

An officer proposes selling 124,042 shares of Dianthus Therapeutics (DNTH).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Dianthus Therapeutics officer Ryan Savitz has filed a notice for the proposed sale of 124,042 common shares, valued at

Read original source

DNTH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.